Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma (Q28291175)

pancreatic ductal adenocarcinoma

inferred from title

1 reference

pancreatic ductal carcinoma

inferred from title

1 reference

Chang-Yong Zhao

1

0 references

Zi-Jian Guo

2

0 references

Sai-Min Dai

3

0 references

Yong Zhang

4

0 references

Jun-Jing Zhou

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

5

0 references

language of work or name

English

0 references

publication date

October 2013

0 references

published in

Tumor Biology

0 references

volume

34

0 references

issue

5

0 references

page(s)

2983-7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Molecular markers associated with outcome and metastasis in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Expression of protein S100A4 is a predictor of recurrence in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0862-4

Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696030

12 December 2020

Coexpression of Bcl-2 with epithelial-mesenchymal transition regulators is a prognostic indicator in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696030

12 December 2020

Expression of immunoreactive E-cadherin adhesion molecules in human cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696030

12 December 2020

Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696030

12 December 2020

Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23696030

12 December 2020